391 related articles for article (PubMed ID: 11907194)
1. Characterization of mu, kappa, and delta opioid binding in amphibian whole brain tissue homogenates.
Newman LC; Sands SS; Wallace DR; Stevens CW
J Pharmacol Exp Ther; 2002 Apr; 301(1):364-70. PubMed ID: 11907194
[TBL] [Abstract][Full Text] [Related]
2. Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes.
Emmerson PJ; Liu MR; Woods JH; Medzihradsky F
J Pharmacol Exp Ther; 1994 Dec; 271(3):1630-7. PubMed ID: 7996478
[TBL] [Abstract][Full Text] [Related]
3. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
4. Naloxone and its quaternary derivative, naloxone methiodide, have differing affinities for mu, delta, and kappa opioid receptors in mouse brain homogenates.
Lewanowitsch T; Irvine RJ
Brain Res; 2003 Feb; 964(2):302-5. PubMed ID: 12576191
[TBL] [Abstract][Full Text] [Related]
5. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys.
Ko MC; Lee H; Harrison C; Clark MJ; Song HF; Naughton NN; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2003 Jul; 306(1):179-86. PubMed ID: 12676881
[TBL] [Abstract][Full Text] [Related]
6. Delta and mu opioid receptors from the brain of a urodele amphibian, the rough-skinned newt Taricha granulosa: cloning, heterologous expression, and pharmacological characterization.
Bradford CS; Walthers EA; Stanley DJ; Baugh MM; Moore FL
Gen Comp Endocrinol; 2006 May; 146(3):275-90. PubMed ID: 16375901
[TBL] [Abstract][Full Text] [Related]
7. mu/delta Cooperativity and opposing kappa-opioid effects in nucleus accumbens-mediated antinociception in the rat.
Schmidt BL; Tambeli CH; Levine JD; Gear RW
Eur J Neurosci; 2002 Mar; 15(5):861-8. PubMed ID: 11906528
[TBL] [Abstract][Full Text] [Related]
8. Mu-opioid receptor specific antagonist cyprodime: characterization by in vitro radioligand and [35S]GTPgammaS binding assays.
Márki A; Monory K; Otvös F; Tóth G; Krassnig R; Schmidhammer H; Traynor JR; Roques BP; Maldonado R; Borsodi A
Eur J Pharmacol; 1999 Oct; 383(2):209-14. PubMed ID: 10585536
[TBL] [Abstract][Full Text] [Related]
9. Comparison of G-protein activation in the brain by mu-, delta-, and kappa-opioid receptor agonists in mu-opioid receptor knockout mice.
Park Y; Ma T; Tanaka S; Jang C; Loh HH; Ko KH; Ho IK
Brain Res Bull; 2000 Jul; 52(4):297-302. PubMed ID: 10856828
[TBL] [Abstract][Full Text] [Related]
10. Expression of mu-, delta- and kappa-opioid receptors in baculovirus-infected insect cells.
Obermeier H; Wehmeyer A; Schulz R
Eur J Pharmacol; 1996 Dec; 318(1):161-6. PubMed ID: 9007528
[TBL] [Abstract][Full Text] [Related]
11. Monoarthritis induces complex changes in mu-, delta- and kappa-opioid binding sites in the superficial dorsal horn of the rat spinal cord.
Besse D; Weil-Fugazza J; Lombard MC; Butler SH; Besson JM
Eur J Pharmacol; 1992 Nov; 223(2-3):123-31. PubMed ID: 1335878
[TBL] [Abstract][Full Text] [Related]
12. Interaction of co-expressed mu- and delta-opioid receptors in transfected rat pituitary GH(3) cells.
Martin NA; Prather PL
Mol Pharmacol; 2001 Apr; 59(4):774-83. PubMed ID: 11259622
[TBL] [Abstract][Full Text] [Related]
13. DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. I. A mixed opioid agonist with potent antinociceptive activity.
Gengo PJ; Pettit HO; O'Neill SJ; Wei K; McNutt R; Bishop MJ; Chang KJ
J Pharmacol Exp Ther; 2003 Dec; 307(3):1221-6. PubMed ID: 14534368
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
Mitrovic I; Napier TC
J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342
[TBL] [Abstract][Full Text] [Related]
15. Characterization of opioid receptors on smooth muscle cells from guinea pig stomach.
Zhang L; Gu ZF; Pradhan T; Jensen RT; Maton PN
Am J Physiol; 1992 Mar; 262(3 Pt 1):G461-9. PubMed ID: 1312793
[TBL] [Abstract][Full Text] [Related]
16. Characterization of specific opioid binding sites in neural membranes from the myenteric plexus of porcine small intestine.
Townsend D; Portoghese PS; Brown DR
J Pharmacol Exp Ther; 2004 Jan; 308(1):385-93. PubMed ID: 14569065
[TBL] [Abstract][Full Text] [Related]
17. Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum.
Schoffelmeer AN; Hogenboom F; Mulder AH
Br J Pharmacol; 1997 Oct; 122(3):520-4. PubMed ID: 9351509
[TBL] [Abstract][Full Text] [Related]
18. Standard opioid agonists activate heteromeric opioid receptors: evidence for morphine and [d-Ala(2)-MePhe(4)-Glyol(5)]enkephalin as selective μ-δ agonists.
Yekkirala AS; Kalyuzhny AE; Portoghese PS
ACS Chem Neurosci; 2010 Feb; 1(2):146-54. PubMed ID: 22816017
[TBL] [Abstract][Full Text] [Related]
19. The stimulatory effect of mu- and delta-opioid receptors on bovine pinealocyte melatonin synthesis.
Chuchuen U; Ebadi M; Govitrapong P
J Pineal Res; 2004 Nov; 37(4):223-9. PubMed ID: 15485547
[TBL] [Abstract][Full Text] [Related]
20. Dynorphin selectively augments the M-current in hippocampal CA1 neurons by an opiate receptor mechanism.
Madamba SG; Schweitzer P; Siggins GR
J Neurophysiol; 1999 Oct; 82(4):1768-75. PubMed ID: 10515966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]